BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17391311)

  • 1. Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantation.
    Dobr T; Passweg J; Weber C; Tichelli A; Heim D; Meyer J; Gratwohl A; Waltimo T
    Eur J Haematol; 2007 Jun; 78(6):495-9. PubMed ID: 17391311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral health comparisons between children attending an Aboriginal health service and a Government school dental service in a regional location.
    Parker EJ; Jamieson LM
    Rural Remote Health; 2007; 7(2):625. PubMed ID: 17474830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chemotherapy and hematopoietic stem cell transplantation pre and postterm DMFT scores: a preliminary study.
    Ertas ET; Kurnaz F; Zorba YO; Kocyigit I; Sisman Y; Kaynar L; Sekerci AE; Ertas H; Cetin M
    Niger J Clin Pract; 2014; 17(1):32-7. PubMed ID: 24326804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental fear and adult oral health in Australia.
    Armfield JM; Slade GD; Spencer AJ
    Community Dent Oral Epidemiol; 2009 Jun; 37(3):220-30. PubMed ID: 19508270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation.
    Yamagata K; Onizawa K; Yanagawa T; Hasegawa Y; Kojima H; Nagasawa T; Yoshida H
    Bone Marrow Transplant; 2006 Aug; 38(3):237-42. PubMed ID: 16850033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental caries in relation to salivary factors in Saudi population groups.
    Farsi N
    J Contemp Dent Pract; 2008 Mar; 9(3):16-23. PubMed ID: 18335115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT.
    Uutela P; Passweg J; Halter J; Weiger R; Waltimo T; Mauramo M
    Eur J Haematol; 2019 Apr; 102(4):351-356. PubMed ID: 30632215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Xu LP; Luo XH; Chang YJ; Liu DH; Liu KY; Chen YH; Huang XJ
    Ann Hematol; 2009 Oct; 88(10):1015-24. PubMed ID: 19319533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.